Reporting of preclinical tumor-graft cancer therapeutic studies.
about
Optimized design and analysis of preclinical intervention studies in vivoA meta-analysis of threats to valid clinical inference in preclinical research of sunitinibAnticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer.Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance.Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.Design and Reporting of Targeted Anticancer Preclinical Studies: A Meta-Analysis of Animal Studies Investigating Sorafenib Antitumor Efficacy.
P2860
Q28595545-C42F571D-F39A-4E1A-B3EE-3B145BCCABC6Q28606538-E2B4A40A-9D32-43A9-9739-60A6A889AA97Q36293343-A508EEA2-F31A-4F23-AC39-A657BD85A6E6Q37079087-32797D06-390E-4827-9CBD-445C96CD2F81Q38758370-BB0D2EFA-DFD9-4ADD-AB98-7C05B17F4663Q38823705-0DCC7EDE-B827-4A6D-B06B-E57228123B60Q39710264-BC1D8842-7A72-48AA-8332-867A8A664804
P2860
Reporting of preclinical tumor-graft cancer therapeutic studies.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Reporting of preclinical tumor-graft cancer therapeutic studies
@nl
Reporting of preclinical tumor-graft cancer therapeutic studies.
@ast
Reporting of preclinical tumor-graft cancer therapeutic studies.
@en
type
label
Reporting of preclinical tumor-graft cancer therapeutic studies
@nl
Reporting of preclinical tumor-graft cancer therapeutic studies.
@ast
Reporting of preclinical tumor-graft cancer therapeutic studies.
@en
prefLabel
Reporting of preclinical tumor-graft cancer therapeutic studies
@nl
Reporting of preclinical tumor-graft cancer therapeutic studies.
@ast
Reporting of preclinical tumor-graft cancer therapeutic studies.
@en
P2093
P2860
P3181
P356
P1476
Reporting of preclinical tumor-graft cancer therapeutic studies.
@en
P2093
Adam J Pascoe
Elizabeth Sugar
Nilofer Azad
P2860
P304
P3181
P356
10.4161/CBT.21782
P407
P577
2012-08-16T00:00:00Z